EGFR and cancer: The engineered GE11-HUVEC-EVs-Vin showed relatively less effect on the migration and proliferation of the normal HEK293 cells, which depicts the relative specificity of our GE11-engineered EV-based delivery approach, as EGFR is highly expressed in A549 cancer cells compared to normal HEK293 cells.